Alnylam Pharmaceuticals, Inc. (BVMF:A1LN34)
97.00
-2.78 (-2.79%)
Last updated: Jan 14, 2026, 4:20 PM GMT-3
Alnylam Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence. Standard template. Financial Sources.